FdaApplication

NDA 020549

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE
application_typeNDA
approval_date1997-11-07

Products (3)

ProductActive ingredientStrengthDosage form
FLOVENTFLUTICASONE PROPIONATE0.088MG/INHPOWDER;INHALATION
FLOVENTFLUTICASONE PROPIONATE0.22MG/INHPOWDER;INHALATION
FLOVENTFLUTICASONE PROPIONATE0.044MG/INHPOWDER;INHALATION

3 products